Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.47 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | GNPAT | O15228 | 1/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.41 |
| ▸ | MMP9 | P14780 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL150160 | 1.00 | KMT2A (0.49) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| SCHEMBL27604132 | 1.00 | KMT2A (0.49) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| SCHEMBL29140272 | 0.98 | KMT2A (0.48) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| Magnesium SCHEMBL5524408 | 0.98 | KMT2A (0.48) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| SCHEMBL5524403 | 0.98 | KMT2A (0.48) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| Water SCHEMBL25386650 | 0.98 | KMT2A (0.48) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| Water SCHEMBL15765959 | 0.98 | KMT2A (0.48) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| SCHEMBL29140270 | 0.98 | KMT2A (0.48) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| Glutamine SCHEMBL28063133 | 0.92 | KMT2A (0.61) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| SCHEMBL29380522 | 0.89 | ECE1 (0.43) | KMT2AFOLH1RIMKLANAALAD2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 829 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179519-A1 | PROCESS TO ENHANCE VIRAL VECTOR PRODUCTION IN CELL-CULTURE USING GLYCYL-GLUTAMINE | EVONIK OPERATIONS GMBH (DE) | 2025-06-05 | — | — | US | claimed |
| WO-2025047758-A1 | CULTURE MEDIUM FOR CULTURING VIRUS-PRODUCING CELLS | 味の素株式会社 | 2025-03-06 | — | — | WO | claimed |
| CN-119306788-A | Glycylglutamine potential impurity and preparation method thereof | 湖北泓肽生物科技有限公司 | 2025-01-14 | — | — | CN | claimed |
| EP-4486755-A1 | PROCESS TO ENHANCE VIRAL VECTOR PRODUCTION IN CELL-CULTURE USING GLYCYL-GLUTAMINE | Evonik Operations GmbH (DE) | 2025-01-08 | — | — | EP | claimed |
| CN-118930362-A | Slow-release small-molecule peptide carbon-based fertilizer and composite carbon-based fertilizer with same | 北京锦绣新技术发展有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118804922-A | Method for enhancing viral vector production in cell culture using glycyl-glutamine | 赢创运营有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-117821550-A | Wheat protein hydrolysate rich in glutamine dipeptide as well as preparation method and application thereof | 安琪酵母股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117230000-A | Embryo culture solution additive composition and functional composition, embryo whole-course culture solution, and preparation method and application thereof | 上海明悦医疗科技有限公司 | 2023-12-15 | — | — | CN | claimed |
| WO-2023165969-A1 | PROCESS TO ENHANCE VIRAL VECTOR PRODUCTION IN CELL-CULTURE USING GLYCYL-GLUTAMINE | EVONIK OPERATIONS GMBH (DE) | 2023-09-07 | — | — | WO | claimed |
| US-11666548-B2 | Parenteral nutrition formulation | BAXTER INTERNATIONAL INC. (US) | 2023-06-06 | — | — | US | claimed |
| CN-1740188-A | Prepn process of glycylglutamine | CUI HUANXING (CN) | 2006-03-01 | — | — | CN | claimed |
| WO-2005054274-A1 | NANOFILTRATION OF DIPEPTIDES | FRESENIUS KABI AUSTRIA GMBH (AT) | 2005-06-16 | — | — | WO | claimed |
| WO-2005034980-A1 | GLUTAMINE FOR USE IN TREATING INJURY | UNIVERSITY OF COLORADO (US) | 2005-04-21 | — | — | WO | claimed |
| US-20050059610-A1 | Glutamine for use in treating injury | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 2005-03-17 | — | — | US | claimed |
| CN-1532204-A | Process for preparing glycyl gtutamine | 四川三高生化股份有限公司 | 2004-09-29 | — | — | CN | claimed |
| EP-1000541-B1 | Defined serumfree medical solution for ophthalmology | SKELNIK DEBRA L (US) | 2004-01-14 | — | — | EP | claimed |
| US-6429220-B1 | COMPRISES AN ISOTHIAZOLONE COMPOUND AND AN AMINOCARBOXYLIC ACID | KURITA WATER INDUSTRIES LTD. (JP) | 2002-08-06 | — | — | US | claimed |
| US-6153582-A | USED FOR PRESERVATION AND ENHANCEMENT OF HUMAN CORNEAL TISSUE, SPECIFIED AS THE TIME BETWEEN REMOVAL FROM THE DONOR AND TRANSPLANTATION | BAUSCH & LOMB SURGICAL, INC. (US) | 2000-11-28 | — | — | US | claimed |
| EP-1000541-A1 | Defined serumfree medical solution for ophthalmology | Bausch & Lomb Surgical, Inc. (US) | 2000-05-17 | — | — | EP | claimed |
| EP-0220379-B1 | USE OF GLUTAMINE IN THE FORM OF ITS DI- AND TRIPEPTIDE IN A NUTRIENT MEDIUM FOR CELL CULTURE | Pharmacia GmbH (DE) | 1990-05-09 | — | — | EP | claimed |